Variant report
Variant | esv3390874 |
---|---|
Chromosome Location | chr13:62236301-62237749 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186317715 | chr13:62236314-62236315 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190716529 | chr13:62236320-62236321 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180723883 | chr13:62236523-62236524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570668234 | chr13:62236544-62236545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575783260 | chr13:62236551-62236552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544486195 | chr13:62236562-62236563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2497624 | chr13:62236593-62236594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554786550 | chr13:62236634-62236635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553170263 | chr13:62236637-62236638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200702255 | chr13:62236703-62236704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566711723 | chr13:62236705-62236706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs202070542 | chr13:62236706-62236707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534079534 | chr13:62236707-62236708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558896071 | chr13:62236708-62236709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577930480 | chr13:62236709-62236710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533290320 | chr13:62236718-62236719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34448370 | chr13:62236720-62236721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs66715144 | chr13:62236721-62236722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545090964 | chr13:62236725-62236726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186255105 | chr13:62236731-62236732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs397727426 | chr13:62236732-62236733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201232423 | chr13:62236737-62236738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140100706 | chr13:62236751-62236752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141945597 | chr13:62236759-62236760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34113001 | chr13:62236763-62236764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575628960 | chr13:62236776-62236777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59756022 | chr13:62236796-62236797 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs561137480 | chr13:62236801-62236802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377368932 | chr13:62236808-62236809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573103318 | chr13:62236823-62236824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540483270 | chr13:62236825-62236826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12873683 | chr13:62236829-62236830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201503070 | chr13:62236830-62236831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59254707 | chr13:62236834-62236835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191178610 | chr13:62236843-62236844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182641598 | chr13:62236845-62236846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs60183214 | chr13:62236851-62236852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs58190653 | chr13:62236857-62236858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569627496 | chr13:62236877-62236878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565252059 | chr13:62236879-62236880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185805557 | chr13:62236882-62236883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199735191 | chr13:62236887-62236888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550282219 | chr13:62236889-62236890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529279871 | chr13:62236937-62236938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548863910 | chr13:62236980-62236981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190366459 | chr13:62237003-62237004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34486297 | chr13:62237008-62237009 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs35278423 | chr13:62237026-62237027 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs533988969 | chr13:62237031-62237032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182961267 | chr13:62237110-62237111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Esophageal squamous carcinoma | 20200074 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Bipolar disorder | 19214233 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62236200-62236400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr13:62236400-62236800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr13:62236800-62237400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr13:62237400-62238000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:62237600-62238400 | Enhancers | HepG2 | liver |
6 | chr13:62237600-62240800 | Enhancers | Fetal Intestine Large | intestine |